Showing results (111-120 of 1,768) with videos related to

Sort By:
Pageof 177
Hormone Research|October 25, 2000
Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhoodE I Mayer, M Reuter, R E Dopfer, et al.
European Journal of Pediatrics|September 4, 1998
Reference values for height and weight in Prader-Willi syndrome based on 315 patientsH A Wollmann, U Schultz, M L Grauer, et al.
Endocrinology|December 14, 2004
Structural analysis of human growth hormone with respect to the dominant expression of growth hormone (GH) mutations in isolated GH deficiency type IIDaniel I Iliev, Nicola E Wittekindt, Michael B Ranke, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|March 16, 2007
Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II)G Binder, D I Iliev, P E Mullis, et al.
Acta Endocrinologica|December 1, 1987
The polymorphic pattern of somatomedins during human developmentW F Blum, M B Ranke, B Lechner, et al.
Pediatric Nephrology (Berlin, Germany)|June 23, 2022
Kidney disease and thyroid dysfunction: the chicken or egg problemFabian Echterdiek, Michael B Ranke, Vedat Schwenger, et al.
Hormone Research|May 29, 2004
IGFs, IGFBPs, IGF-binding sites and biochemical markers of bone metabolism during differentiation in human pulp fibroblastsKatharina M Reichenmiller, Christel Mattern, Michael B Ranke, et al.
Pediatric Diabetes|December 6, 2003
Ketoacidosis at onset of type 1 diabetes mellitus in children--frequency and clinical presentationAndreas Neu, Andre Willasch, Stefan Ehehalt, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive childrenC P Schwarze, H A Wollmann, G Binder, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)Martin W Elmlinger, Werner Kühnel, Matthias M Weber, et al.
Pageof 177